Drug intelligence / Profile preview

New Wumei Pill

Development stage
Preclinical
Lead developer
Beijing University of Chinese Medicine East Hospital
Administration
Oral
01

Overview

New Wumei Pill (Xin Wumei Wan) is a Traditional Chinese Medicine (TCM) herbal formula developed by Dongfang Hospital of Beijing University of Chinese Medicine for the treatment of ulcerative colitis. It is a modern modification of the classic Wumei Wan formula, which was originally described in the *Shanghan Lun* for treating 'Jueyin' syndrome. The 'New' formulation is specifically optimized to address the 'cold-heat complex' pathology often observed in chronic inflammatory bowel diseases. The formula typically contains a mixture of botanical ingredients such as Mume Fructus, Coptidis Rhizoma, and other herbs that work synergistically to regulate intestinal immune homeostasis, enhance intestinal barrier function, and suppress pro-inflammatory signaling pathways. It is currently being investigated in clinical trials in China as an adjunctive or standalone therapy for patients with moderate active ulcerative colitis.

Other names
Xin Wumei WanModified Wumei Pill
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on New Wumei Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Wumei Pill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call